Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California

被引：0
|
作者：
Arti Parikh-Patel
Richard H. White
Mark Allen
Rosemary Cress
机构：
[1] Public Health Institute,California Cancer Registry
[2] University of California Davis School of Medicine,Department of Internal Medicine
[3] University of California,Department of Public Health Sciences
来源：
Cancer Causes & Control | 2008年 / 19卷
关键词：
Cancer; Systemic lupus erythematosus; Malignancy; Autoimmune diseases; Hematologic neoplasms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：887 / 894
页数：7
相关论文
共 50 条
  • [41] The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study
    Lin, Y-C
    Yen, J-H
    Chang, S-J
    Lin, Y-C
    LUPUS, 2012, 21 (11) : 1250 - 1256
  • [42] An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus
    Yeo, Jina
    Seo, Min-Seok
    Hwang, In Cheol
    Shim, Jae-Yong
    ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (09) : 614 - 620
  • [43] Clinical manifestations of patients with Systemic Lupus Erythematosus (SLE) in Khyber Pakhtunkhwa
    Khan, Adnan
    Shah, Mohammad Hassan
    Nauman, Muhammad
    Hakim, Itizaz
    Shahid, Gulrukh
    Niaz, Palwasha
    Sethi, Haseeba
    Aziz, Shumaila
    Arabdin, Maria
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (08) : 1180 - 1185
  • [44] Malignancy in Systemic Lupus Erythematosus: A Nationwide Cohort Study in Taiwan
    Chen, Yi-Ju
    Chang, Yun-Ting
    Wang, Chang-Bi
    Wu, Chun-Ying
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (12) : 1150.e1 - 1150.e6
  • [45] Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)
    Witt, M.
    Grunke, M.
    Proft, F.
    Baeuerle, M.
    Aringer, M.
    Burmester, G.
    Chehab, G.
    Fiehn, C.
    Fischer-Betz, R.
    Fleck, M.
    Freivogel, K.
    Haubitz, M.
    Koetter, I.
    Lovric, S.
    Metzler, C.
    Rubberth-Roth, A.
    Schwarting, A.
    Specker, C.
    Tony, H-P
    Unger, L.
    Wassenberg, S.
    Doerner, T.
    Schulze-Koops, H.
    LUPUS, 2013, 22 (11) : 1142 - 1149
  • [46] Systemic lupus erythematosus and malignancies risk
    Song Mao
    Hua Shen
    Jianhua Zhang
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 253 - 262
  • [47] Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang Lupus Cohort in Seoul, Korea
    Chun, BC
    Bae, SC
    LUPUS, 2005, 14 (08) : 635 - 638
  • [48] Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea
    Han, Jung-Yong
    Kim, Hyoungyoung
    Jung, Sun-Young
    Jang, Eun Jin
    Cho, Soo-Kyung
    Sung, Yoon-Kyoung
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [49] Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea
    Jung-Yong Han
    Hyoungyoung Kim
    Sun-Young Jung
    Eun Jin Jang
    Soo-Kyung Cho
    Yoon-Kyoung Sung
    Arthritis Research & Therapy, 23
  • [50] Systemic lupus erythematosus and the risk of malignancy
    Cibere, J
    Sibley, J
    Haga, M
    LUPUS, 2001, 10 (06) : 394 - 400
12345